| Hotspot mutations in H3F3A and IDH1 define distinct epigenetic and biological subgroups of glioblastoma D Sturm, H Witt, V Hovestadt, DA Khuong-Quang, DTW Jones, ... Cancer cell 22 (4), 425-437, 2012 | 1947 | 2012 |
| Intertumoral heterogeneity within medulloblastoma subgroups FMG Cavalli, M Remke, L Rampasek, J Peacock, DJH Shih, B Luu, ... Cancer cell 31 (6), 737-754. e6, 2017 | 1043 | 2017 |
| Subgroup-specific structural variation across 1,000 medulloblastoma genomes PA Northcott, DJH Shih, J Peacock, L Garzia, A Sorana Morrissy, ... Nature 488 (7409), 49-56, 2012 | 962 | 2012 |
| New brain tumor entities emerge from molecular classification of CNS-PNETs D Sturm, BA Orr, UH Toprak, V Hovestadt, DTW Jones, D Capper, M Sill, ... Cell 164 (5), 1060-1072, 2016 | 826 | 2016 |
| Multiple recurrent genetic events converge on control of histone lysine methylation in medulloblastoma PA Northcott, Y Nakahara, X Wu, L Feuk, DW Ellison, S Croul, S Mack, ... Nature genetics 41 (4), 465-472, 2009 | 495 | 2009 |
| Clonal selection drives genetic divergence of metastatic medulloblastoma X Wu, PA Northcott, A Dubuc, AJ Dupuy, DJH Shih, H Witt, S Croul, ... Nature 482 (7386), 529-533, 2012 | 482 | 2012 |
| Improved ATM kinase inhibitor KU-60019 radiosensitizes glioma cells, compromises insulin, AKT and ERK prosurvival signaling, and inhibits migration and invasion SE Golding, E Rosenberg, N Valerie, I Hussaini, M Frigerio, XF Cockcroft, ... Molecular cancer therapeutics 8 (10), 2894-2902, 2009 | 388 | 2009 |
| The miR-17/92 polycistron is up-regulated in Sonic Hedgehog–driven medulloblastomas and induced by N-myc in Sonic Hedgehog–treated cerebellar neural precursors PA Northcott, A Fernandez-L, JP Hagan, DW Ellison, W Grajkowska, ... Cancer research 69 (8), 3249-3255, 2009 | 337 | 2009 |
| Integrated (epi)-genomic analyses identify subgroup-specific therapeutic targets in CNS rhabdoid tumors J Torchia, B Golbourn, S Feng, KC Ho, P Sin-Chan, A Vasiljevic, ... Cancer cell 30 (6), 891-908, 2016 | 224 | 2016 |
| TERT promoter mutations are highly recurrent in SHH subgroup medulloblastoma M Remke, V Ramaswamy, J Peacock, DJH Shih, C Koelsche, ... Acta neuropathologica 126, 917-929, 2013 | 199 | 2013 |
| Molecular subgroups of atypical teratoid rhabdoid tumours in children: an integrated genomic and clinicopathological analysis J Torchia, D Picard, L Lafay-Cousin, CE Hawkins, SK Kim, L Letourneau, ... The lancet oncology 16 (5), 569-582, 2015 | 181 | 2015 |
| Markers of survival and metastatic potential in childhood CNS primitive neuro-ectodermal brain tumours: an integrative genomic analysis D Picard, S Miller, CE Hawkins, E Bouffet, HA Rogers, TSY Chan, SK Kim, ... The lancet oncology 13 (8), 838-848, 2012 | 177 | 2012 |
| CNS-PNETs with C19MC amplification and/or LIN28 expression comprise a distinct histogenetic diagnostic and therapeutic entity T Spence, P Sin-Chan, D Picard, M Barszczyk, K Hoss, M Lu, SK Kim, ... Acta neuropathologica 128, 291-303, 2014 | 165 | 2014 |
| Sunitinib induces apoptosis and growth arrest of medulloblastoma tumor cells by inhibiting STAT3 and AKT signaling pathways F Yang, V Jove, H Xin, M Hedvat, TE Van Meter, H Yu Molecular Cancer Research 8 (1), 35-45, 2010 | 121 | 2010 |
| Sorafenib inhibits signal transducer and activator of transcription 3 signaling associated with growth arrest and apoptosis of medulloblastomas F Yang, TE Van Meter, R Buettner, M Hedvat, W Liang, CM Kowolik, ... Molecular cancer therapeutics 7 (11), 3519-3526, 2008 | 104 | 2008 |
| Medulloblastoma subgroups remain stable across primary and metastatic compartments X Wang, AM Dubuc, V Ramaswamy, S Mack, DMA Gendoo, M Remke, ... Acta neuropathologica 129, 449-457, 2015 | 100 | 2015 |
| Genetic and epigenetic inactivation of Kruppel-like factor 4 in medulloblastoma Y Nakahara, PA Northcott, M Li, PN Kongkham, C Smith, H Yan, S Croul, ... Neoplasia 12 (1), 20-27, 2010 | 97 | 2010 |
| Microarray analysis of MRI-defined tissue samples in glioblastoma reveals differences in regional expression of therapeutic targets T Van Meter, C Dumur, N Hafez, C Garrett, H Fillmore, WC Broaddus Diagnostic molecular pathology 15 (4), 195-205, 2006 | 90 | 2006 |
| A C19MC-LIN28A-MYCN oncogenic circuit driven by hijacked super-enhancers is a distinct therapeutic vulnerability in ETMRs: a lethal brain tumor P Sin-Chan, I Mumal, T Suwal, B Ho, X Fan, I Singh, Y Du, M Lu, N Patel, ... Cancer cell 36 (1), 51-67. e7, 2019 | 82 | 2019 |
| Failure of human rhombic lip differentiation underlies medulloblastoma formation LD Hendrikse, P Haldipur, O Saulnier, J Millman, AH Sjoboen, ... Nature 609 (7929), 1021-1028, 2022 | 71 | 2022 |
Michael TaylorTexas Children's Hospital, Baylor College of MedicineVerified email at bcm.edu
